Brief: Sciclone Pharmaceuticals Announces Exclusive License Agreement
Sept 16 (Reuters) - SciClone Pharmaceuticals (Holdings) Ltd
6600.HK :
* ANNOUNCES EXCLUSIVE LICENSE AGREEMENT FOR HSP90-PI3K
MINIATURE
DRUG CONJUGATES WITH TARVEDA THERAPEUTICS, INC
* WILL PAY TARVEDA AN UPFRONT FEE IN CASH WITH RIGHT TO MAKE
AN
EQUITY INVESTMENT IN TARVEDA
Source text for Eikon: ID:nHKS2CLFyZ
Further company coverage: 6600.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on SciClone Pharmaceuticals (Holdings)
See all newsOneRobotics surges on plan to buy more shares
Brief: Onerobotics (Shenzhen) To Procure Affiliate Of Co To Acquire 59.9% Stake Of Nanoleaf Limited, Others
Brief: OneRobotics (Shenzhen) Says Final Offer Price Under Global Offering Is HK$73.80 Per H Share
Brief: Sciclone Pharmaceuticals (Holdings) Announces Proposal For Privatisation Of Co By Silver Pegasus Investment
Brief: SciClone Pharmaceuticals Says Trading In Shares Halted